Search results

Private Credit: Not all banking partnerships are created equal

Reference Hub13 March 2025By Federated Hermes

In an increasingly competitive direct lending landscape, deal origination is critical to achieving consistent returns across the asset class.

The business case for nature: why companies need to act

January/February 2025 (Magazine)

As an ex-physicist, I feel confident in proclaiming that economics is not a science but, rather, the study of human behaviour on a mass scale. Why does that matter?

Switzerland sees uptick of pension funds decarbonising portfolios

13 March 2024

However, only 1% of Swiss pension assets are invested to have a positive impact on society, the environment and the climate, research finds

Ethos joins ADEME and others to assess companies’ transition plans before AGMs

12 March 2024

SIF and FinanceClimAct will publish detailed analysis on their websites before Say on Climate votes

Perspective: André Hoffmann – Green results, not greenbacks

February 2020 (Magazine)

Roche heir and pharmaceutical tycoon André Hoffmann outlines his view of a more sustainable model of capitalism 

Fiorino: Leverage will tear us apart, again

Reference Hub16 December 2022By Federated Hermes

Fiorino charts the gravitationally risky path of the UK pension system after it veered dangerously close to the point of implosion.

ASIP ESG reporting guidelines lay obstacle course for Swiss pension funds

29 May 2024

Pension funds have taken the ASIP ESG reporting standards as an opportunity to start or expand public ESG reporting

Large Swiss firms fail to assess impact of digital transformation on workforce

19 December 2023

However, Switzerland’s largest listed companies researched in Ethos study have improved their scores with regard to digital responsibly

Roche fund picks new head

8 January 2008

[15:15 CET 08-01] SWITZERLAND – The Basle-based pension fund of Swiss drugs giant Roche has appointed Robert Aeby as its new head.

Roche departure strengthens Aon's Swiss team

1 December 2008

[16:30 CET 01-12] SWITZERLAND – Matthias Pfiffner, international benefits manager at Roche, has left the pharmaceutical giant to join the pensions team at Aon Consulting Switzerland.

People moves: Clara-Pensions names new chief operating officer

28 March 2024

Plus: LCP appoints independent chair; IFM Investors recruits head of global consultant relations

Roche picks Watson

July 2002 (Magazine)

Roche pension chief ‘in Swissfirst trade’ - paper

28 November 2006

SWITZERLAND – The pension investment head for Swiss pharmaceuticals giant Roche personally profited from trading with shares of Swissfirst bank in September 2005, Swiss daily Blick reported today.

T. Rowe names Kennedy CEO as Roche retires

16 March 2006

US – Asset management firm T. Rowe Price Group has named equities chief James Kennedy to be its new president and chief executive when George Roche retires.

CEO commitment on mental health lacking, CCLA global benchmark shows

10 October 2023

There is a clear economic case for investment in mental health at work, says CCLA stewardship lead

Roche hires ex-Aon Europe manager Kistemaker

12 August 2005

GLOBAL – Aon Consulting’s former manager of international benefits for continental Europe, Ruud Kistemaker, has joined drugs firm Roche as global benefits manager.

A closer look at European equities

Reference Hub1 October 2024By STOXX

Interview with Arun Singhal, Global Head of Product Management at STOXX.

Better the equity market devil you know?

June 2023 (Magazine)

Being a large equity investor in a relatively small domestic market can have advantages as well as drawbacks. Proximity to the market and its infrastructure, good knowledge of corporates and corporate leaders, and the ability to exercise strong influence as an owner, potentially a stable long-term one, all count among the advantages. The need to avoid concentration – in terms of position, sizing and overall allocations – and idiosyncratic sector exposure are among the challenges. 

Roche picks Watson Wyatt as full service provider

12 June 2002

UK – The €620m UK pension fund of Swiss pharmaceuticals group, Roche, has appointed Watson Wyatt as full pension service provider. The deal includes actuarial, administration, investment consulting and communications services. Watson Wyatt take over from previous service providers, Bacon & Woodrow.

Switzerland: Workplace pension reform faces referendum test

Top 1000 Pension Funds 2024

The country is introducing regulations on greenwashing and fund investments, while debating how to fund the first and second-pillar pension systems